Five Top Stocks From Wall Street Analysts For A Choppy Market

Four-star Meacham reiterated his buy rating on Feb. 14 and ramped up his price target to $100 from $85. The new target is 18 percent higher than Friday’s closing price.

San Diego-based Neurocrine has received eight consecutive buy ratings from analysts in the last three months.

4. Abiomed (ABMD)

Beta 0.30, up 39 percent in quarter

Abiomed is the manufacturer of the AbioCor artificial heart and heart pump Impella. Shares in Abiomed rose 15 percent from $234 on Feb. 13 to the current share price of $268 after a key regulatory approval.

The company has now received an expanded Food and Drug Administration premarket approval for the Impella 2.5 and Impella CP heart pumps during elective and urgent high risk percutaneous coronary intervention procedures.

This is very good news, according to top Piper Jaffray analyst Matt O’Brien.

He keeps a “buy” rating on Abiomed and describes the approval as “a nod from the FDA on total heart recovery.” In his Feb. 13 report, O’Brien now forecasts improved growth prospects for Abiomed and recommends starting or building positions in the stock.

Overall, this stock has scored six buy ratings and just one hold rating in the last three months. At $289, the average analyst price target indicates upside potential of just over 11 percent.

5. Bofl Holding (BOFI)

Beta 0.40, up 48 percent in quarter

BofI Holding, the parent company of BofI Federal Bank, is hitting on all cylinders according to B. Riley FBR’s Steve Moss. The company has just reported solid results and strong loan growth for the December quarter.

Most importantly, says Moss, BOFI was upbeat on loan growth and expansion opportunities, and this can create substantial earnings growth. He notes that the company repurchased shares in the fourth quarter, and this reflects its “expectations for strong growth in profitability.”

In his Jan. 31 investor report, he concludes: “BOFI remains a quality franchise with clean credit, solid loan growth, ample capital, and strong profitability.”

View single page >> |

Disclaimer: TipRanks is an independent cloud based service that measures and ranks digitally published financial advice. TipRanks' natural language processing (NLP) algorithms aggregate and ...

How did you like this article? Let us know so we can better customize your reading experience.


Leave a comment to automatically be entered into our contest to win a free Echo Show.